Concepedia

Liping Su

LS

21

Publications

610

Citations

15

H-Index

2016

Active since

Affiliations

Shanxi Provincial Cancer Hospital(Current)

Shanxi Medical University

Hebei Medical University

First Affiliated Hospital of Zhengzhou University

Fourth Hospital of Hebei Medical University

Liping Su is an author at Shanxi Provincial Cancer Hospital specializing in medicine, oncology, and immunology.

Top concepts

Publications per year

2016–2023

21

Publications

21

DDGP versus SMILE in Newly Diagnosed Advanced Natural Killer/T-Cell Lymphoma: A Randomized Controlled, Multicenter, Open-label Study in China

Xin Li, Yingying Cui, Zhenchang Sun et al. · Clinical Cancer Research · 2016 · 138 citations

Efficacy and Safety of a Pegasparaginase-Based Chemotherapy Regimen vs an L-asparaginase–Based Chemotherapy Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell Lymphoma

Xinhua Wang, Lei Zhang, Xiangli Liu et al. · JAMA Oncology · 2022 · 55 citations · Full text

Anthracycline dose optimisation in patients with diffuse large B-cell lymphoma: a multicentre, phase 3, randomised, controlled trial

Pengpeng Xu, Di Fu, Jianyong Li et al. · The Lancet Haematology · 2019 · 46 citations

, , +6

Primary breast diffuse large B‐cell lymphoma in the rituximab era: Therapeutic strategies and patterns of failure

Shaoxuan Hu, Yuqin Song, Xiuhua Sun et al. · Cancer Science · 2018 · 44 citations · Full text

Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: a prospective, multicentre, non-interventional study

Jianqiu Wu, Yongping Song, Liping Su et al. · BMC Cancer · 2016 · 32 citations · Full text

Rows per page

1–5 of 21